Relay Therapeutics Stock Up 235% This Past Year as One Fund Lifts Bet to $110 Millionfool.comRelay Therapeutics develops precision medicines targeting oncology and genetic diseases, leveraging proprietary computational technology.
Structure Therapeutics Stock Surges 200% This Past Year as One Fund Cuts Stake by $15.5 Millionfool.comThis clinical-stage biotech develops oral therapies for chronic diseases, with a lead candidate targeting type-2 diabetes and obesity.
SomaLogic Acquisition Marks Next Step In Illumina's Advanced Biomarker Pushbenzinga.comIllumina will acquire SomaLogic to expand in proteomics, adding new revenue streams and accelerating tech development in multiomics.
These stocks are gapping in today's sessionchartmill.comThere are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.
